ACADIA Pharmaceuticals Inc Cash Flow Quality Index
ACADIA Pharmaceuticals Inc cash flow quality index. ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Quality Index of 3.84x as of June 2026. Operating cash flow of $134.76 Million exceeds net income of $35.14 Million, indicating high earnings quality where cash backs reported profits. See ACADIA Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ACADIA Pharmaceuticals Inc (2010–2025)
Cash flow quality index of ACADIA Pharmaceuticals Inc from 2010 to 2025. Historical Cash Flow Quality Index for ACADIA Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ACADIA Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
ACADIA Pharmaceuticals Inc Cash Flow Quality Index by Year (2010–2025)
ACADIA Pharmaceuticals Inc cash flow quality index by year from 2010 to 2025. Year-by-year earnings quality comparison for ACADIA Pharmaceuticals Inc. For the full cash flow conversion analysis, see ACADIA Pharmaceuticals Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $109.84 Million | $391.00 Million | ▼ -59.7% |
| 2024 | 0.70x | $157.72 Million | $226.45 Million | ▲ +198.5% |
| 2010 | -0.71x | $-10.70 Million | $15.14 Million | — |